Cargando…
XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma
A novel podophyllotoxin derivative, XWL-1-48, was synthesized as an oral topoisomerase II inhibitor. kDNA decatenation assay indicated that XWL-1-48 significantly inhibited topoisomerase II activity in a concentration-dependent manner. Moreover, the cytotoxicity of XWL-1-48 is more potent than its c...
Autores principales: | Wang, Yajie, Sun, Hua, Xiao, Zhiyan, Zhang, Dan, Bao, Xiuqi, Wei, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577045/ https://www.ncbi.nlm.nih.gov/pubmed/28855652 http://dx.doi.org/10.1038/s41598-017-10577-7 |
Ejemplares similares
-
Identification of Novel 4′-O-Demethyl-epipodophyllotoxin Derivatives as Antitumor Agents Targeting Topoisomerase II
por: Xi, Wenli, et al.
Publicado: (2022) -
Inhibition of Topoisomerase II by a Novel Antitumor Cyclic Depsipeptide, BE‐22179
por: Yoshinari, Tomoko, et al.
Publicado: (1994) -
DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer
por: Wang, Yajie, et al.
Publicado: (2018) -
Ciclopirox Olamine Exerts Tumor-Suppressor Effects via Topoisomerase II Alpha in Lung Adenocarcinoma
por: Yin, Jie, et al.
Publicado: (2022) -
Silybin-Mediated Inhibition of Notch Signaling Exerts Antitumor Activity in Human Hepatocellular Carcinoma Cells
por: Zhang, Song, et al.
Publicado: (2013)